Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study of MOv18 IgE in Patients With Solid Tumours That Express Folate Receptor Alpha [Phase 1]
Phase 1 study of MOv18 IgE in solid tumors expressing folate receptor alpha is currently recruiting, evaluating safety and early signals of …
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies [Phase 2]
This Phase 2 trial investigates changes in disease activity and safety in adults with gynecologic cancers treated with IMGN151, either alone…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 study evaluating oregovomab in combination with bevacizumab and chemotherapy for BRCA wild-type platinum-sensitive recurrent ova…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention [NA]
A clinical study enrolling high-risk women to assess the safety of delaying oophorectomy after tubectomy as a preventive strategy against ov…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating a cancer vaccine therapy in combination with pembrolizumab for advanced fallopian tube, primary per…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer [Phase 1]
Phase 1 clinical trial evaluating autologous T-cells engineered to target KRAS mutations in combination with a KRAS-directed vaccine for met…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. [Phase 2]
Clinical trial update for a Phase 2 study evaluating a combination of oregovomab and niraparib in platinum-sensitive recurrent ovarian cance…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Survivorship Care for Women Living With Ovarian Cancer: (POSTCARE-O) [NA]
The POSTCARE-O study, sponsored by Baylor College of Medicine, is recruiting to evaluate survivorship care for women with ovarian cancer, fo…
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Extended Versus Short Prehabilitation Programme for Patients With Advanced Ovarian Cancer Undergoing Major Surgery [NA]
This clinical trial entry describes a study comparing extended versus short prehabilitation before major surgery in patients with advanced o…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas [Phase 2]
Clinical trial BrUOG 354 assesses nivolumab with or without ipilimumab in ovarian and extrarenal (clear cell) carcinomas; the Phase 2 study …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Intraperitoneal FT536 in Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer [Phase 1]
FT536 is being evaluated in a Phase 1 trial for recurrent ovarian cancer, fallopian tube cancer, and primary peritoneal cancer, and the stud…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
Clinical trial update for a Phase 1 drug-drug interaction study evaluating AZD5335 with itraconazole in ovarian-, fallopian tube-, or primar…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Patent Blue SLN in Early Ovarian Cancer Prospective Study (FIGO I-II) Evaluating Patent Blue SLN Mapping. Injection Into IP/UO Ligaments in Situ. Goals: Assess Feasibility and Accuracy vs Standard Lymphadenectomy to Minimize Surgical Morbidity
A prospective study in early-stage ovarian cancer is evaluating the feasibility and accuracy of Patent Blue SLN mapping versus standard lymp…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery [Phase 2]
Phase 2 clinical trial update on acute normovolemic hemodilution in patients with ovarian cancer undergoing cytoreductive surgery; currently…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery [Phase 3]
A Phase 3 trial of oregovomab plus chemotherapy for newly diagnosed advanced epithelial ovarian cancer after optimal debulking surgery is cu…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and efficacy of COM701 in relapsed platinum-sensitive ovarian cancer is currently recruitin…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Using Aspirin to Improve Immunological Features of Ovarian Tumors [EARLY_Phase 1]
Phase 1 trial is exploring whether aspirin can improve the immunological features of ovarian tumors and related cancers. The study is curren…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer [Phase 1, Phase 2]
Open-label Phase 1/2 trial update evaluating INX-315 in patients with advanced cancers, including breast and ovarian cancer, with recruitmen…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Survivors Uniting for Remote Guided Exercise [NA]
Clinical trial update from Colorado State University about a remote guided exercise program for cancer survivors; the study is currently rec…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers [Phase 1]
Phase 1 study of AB598 as monotherapy and in combination across multiple advanced cancers is ongoing, with status active but not recruiting.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) [Phase 1]
A Phase 1 trial to assess tolerability of different doses of BI 3820768 in adults with advanced relapsed or refractory germ cell tumors, end…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Predictive Clinical and Biological Parameters in Gynecological Cancer [NA]
Ongoing study evaluating predictive clinical and biological parameters across gynecologic cancers (ovarian, endometrial, and cervical cancer…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: DESTINY-PANTUMOUR04
Clinical trial update for the DESTINY-PANTUMOUR04 study sponsored by AstraZeneca, evaluating trastuzumab deruxtecan across multiple cancer t…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Ovarian Cancer Screening and AI [NA]
This clinical trial update describes a study evaluating the use of artificial intelligence to inform ovarian cancer screening recommendation…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced Cancer [Phase 1]
This Clinical Trials Update describes a Phase 1 study of an Fc-engineered anti-CTLA-4 monoclonal antibody by Agenus in patients with advance…